Concepedia

Chalada Suebsuwong

CS

Statistics

Publications

9

Citations

595

H-Index

9

Active since

2014

Affiliations

University of Houston(Current)

Tufts University

University of Oxford

Genomics (United Kingdom)

Ludwig Cancer Research

Chalada Suebsuwong is an author at University of Houston specializing in pharmacology, life sciences, and drug discovery.

ORCID

Publications per year

2014–2022

9

Publications

9

Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1

Malek Najjar, Chalada Suebsuwong, Soumya S. Ray et al. · Cell Reports · 2015 · 145 citations · Full text

, , +16

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors

Peter Canning, Qui Ruan, Tobias Schwerd et al. · Chemistry & Biology · 2015 · 126 citations · Full text

, , +17

Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23

Zhengxiang He, Lili Chen, Jovani Catalan‐Dibene et al. · Cell Metabolism · 2021 · 97 citations · Full text

, , +16

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling

Matouš Hrdinka, Lisa Schlicher, Bing Dai et al. · The EMBO Journal · 2018 · 79 citations · Full text

, , +11

Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors

Courtney Ackeifi, Ethan Swartz, Kunal Kumar et al. · JCI Insight · 2019 · 56 citations · Full text

, , +16

1–5 of 9